Mineralys Therapeutics (MLYS) Shares Outstanding (Diluted) (2022 - 2026)

Mineralys Therapeutics (MLYS) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Outstanding (Dil.) (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	52.24 Mn
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	1.51 Bn
4	NuCana	279.75 Bn	279.75 Bn	-	10.00
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	256.30 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	107.70 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	680.00
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	64.41 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	198.10 Mn
10	Mineralys Therapeutics	2.24 Bn	2.24 Bn	-	82.83 Mn

Download Data